Millennium Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,478
| Closed | -$20.7K | – | 6156 |
|
|
2025
Q1 | $20.7K | Sell |
1,478
-89,058
| -98% | -$1.39M | ﹤0.01% | 5626 |
|
|
2024
Q4 | $1.5M | Buy |
90,536
+39,438
| +77% | +$641K | ﹤0.01% | 3856 |
|
|
2024
Q3 | $967K | Sell |
51,098
-37,782
| -43% | -$766K | ﹤0.01% | 4308 |
|
|
2024
Q2 | $1.29M | Buy |
88,880
+37,502
| +73% | +$626K | ﹤0.01% | 3905 |
|
|
2024
Q1 | $795K | Sell |
51,378
-59,826
| -54% | -$1.29M | ﹤0.01% | 4494 |
|
|
2023
Q4 | $3.11M | Buy |
111,204
+71,803
| +182% | +$1.89M | ﹤0.01% | 3208 |
|
|
2023
Q3 | $1.88M | Sell |
39,401
-48,595
| -55% | -$3.71M | ﹤0.01% | 3610 |
|
|
2023
Q2 | $8.43M | Buy |
87,996
+67,572
| +331% | +$7.35M | ﹤0.01% | 2182 |
|
|
2023
Q1 | $2.32M | Buy |
20,424
+10,150
| +99% | +$1.1M | ﹤0.01% | 3295 |
|
|
2022
Q4 | $1.15M | Buy |
+10,274
| New | +$1.38M | ﹤0.01% | 4026 |
|
|
2022
Q3 | – | Sell |
-54,696
| Closed | -$3.75M | – | 7329 |
|
|
2022
Q2 | $3.75M | Buy |
54,696
+25,232
| +86% | +$2.17M | ﹤0.01% | 3089 |
|
|
2022
Q1 | $4.2M | Sell |
29,464
-33,760
| -53% | -$5.19M | ﹤0.01% | 3122 |
|
|
2021
Q4 | $10.5M | Buy |
63,224
+48,818
| +339% | +$7.76M | 0.01% | 2093 |
|
|
2021
Q3 | $2M | Buy |
14,406
+4,029
| +39% | +$788K | ﹤0.01% | 3921 |
|
|
2021
Q2 | $4.95M | Sell |
10,377
-2,979
| -22% | -$1.26M | ﹤0.01% | 2767 |
|
|
2021
Q1 | $5.5M | Sell |
13,356
-2,481
| -16% | -$1.14M | ﹤0.01% | 2468 |
|
|
2020
Q4 | $7.76M | Buy |
15,837
+1,743
| +12% | +$1.02M | 0.01% | 2024 |
|
|
2020
Q3 | $7.98K | Sell |
14,094
-4,419
| -24% | -$1.47M | 0.01% | 1444 |
|
|
2020
Q2 | $1.76M | Buy |
+18,513
| New | +$1.62M | ﹤0.01% | 2626 |
|
|
2019
Q3 | – | Sell |
-16,093
| Closed | -$1.04M | – | 4397 |
|
|
2019
Q2 | $1.04M | Buy |
16,093
+1,528
| +10% | +$145K | ﹤0.01% | 2790 |
|
|
2019
Q1 | $2M | Buy |
+14,565
| New | +$1.78M | ﹤0.01% | 2412 |
|
|
2018
Q4 | – | Sell |
-738
| Closed | -$112K | – | 3998 |
|
|
2018
Q3 | $112K | Sell |
738
-7,871
| -91% | -$1.27M | ﹤0.01% | 3727 |
|
|
2018
Q2 | $1.48M | Buy |
8,609
+4,318
| +101% | +$705K | ﹤0.01% | 2606 |
|
|
2018
Q1 | $630K | Sell |
4,291
-10,493
| -71% | -$2.01M | ﹤0.01% | 2928 |
|
|
2017
Q4 | $3M | Buy |
14,784
+4,247
| +40% | +$873K | ﹤0.01% | 2028 |
|
|
2017
Q3 | $3.38M | Buy |
10,537
+1,819
| +21% | +$497K | 0.01% | 1880 |
|
|
2017
Q2 | $1.97M | Sell |
8,718
-315
| -3% | -$64.7K | ﹤0.01% | 2079 |
|
|
2017
Q1 | $2.04M | Sell |
9,033
-2,213
| -20% | -$449K | ﹤0.01% | 2001 |
|
|
2016
Q4 | $2.23M | Buy |
+11,246
| New | +$2.45M | ﹤0.01% | 1811 |
|
|
2016
Q2 | – | Sell |
-476
| Closed | -$253K | – | 3409 |
|
|
2016
Q1 | $253K | Sell |
476
-8,299
| -95% | -$4.33M | ﹤0.01% | 2855 |
|
|
2015
Q4 | $6.16M | Buy |
8,775
+3,612
| +70% | +$2.37M | 0.01% | 1224 |
|
|
2015
Q3 | $3.06M | Buy |
5,163
+1,016
| +24% | +$829K | 0.01% | 1637 |
|
|
2015
Q2 | $3.44M | Buy |
+4,147
| New | +$3.62M | 0.01% | 1607 |
|
Other funds holding MCRB
FP
XT
Millennium Management's MCRB Position: Q2 2025 in Review
Millennium Management sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 1,478 shares — an estimated $20.7K sold.
Millennium Management first reported a position in MCRB in Q2 2015 and held it in 33 quarters. The position peaked at $10.5M in Q4 2021. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.
- Millennium Management reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
- Millennium Management sold 1,478 Seres Therapeutics shares in Q2 2025, an estimated $20.7K.
- Millennium Management first reported a position in Seres Therapeutics in Q2 2015 and held it in 33 quarters.
- Millennium Management's Seres Therapeutics position peaked at $10.5M in Q4 2021.
- 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.